Furthermore, RNA profiling and clinical data from 669 patients with gliomas from The Cancer Genome Atlas (TCGA) database showed that high levels of NKILA correlated with high-grade glioblastomas and recurrent gliomas. The gene discussed is NKILA; the disease is central nervous system cancer.